About two in five people in Australia will be diagnosed with cancer by the age of 85. Globally, cancer continues to be the leading cause of death, impacting countless lives. The sobering reality is cancer will touch the lives of many.
Improving how we treat cancer is a top priority. Research is crucial to enhancing patient survival and quality of life, and while progress has been made, there’s still a long way to go.
We plan to expand our clinical trials and research program. We want to be at the forefront of research, playing a crucial role in helping patients now and making a lasting impact on many lives.
You can help us make this happen.
Discover the impact of Icon Cancer Foundation’s research in our 2024/25 Impact Report, showcasing how your support is making a difference for people living with cancer.
2024/25 Impact Report
Research excellence, independently recognised
In 2024, Icon Group became the first Australian organisation to achieve internationally recognised accreditation for both clinical research site quality and workforce excellence. In 2026, we advanced this achievement through renewed certification and Gold-level accreditation, reinforcing our commitment to delivering high-quality clinical research and better outcomes for patients.
Make an impact
Your generous donation can make a significant difference to the future of cancer care